Mednow Opens Alberta Pharmacy Location
Mednow Inc. (OTCQX:MDNWF) has officially opened a new pharmacy facility in Calgary, Alberta, enhancing its national infrastructure and commitment to holistic patient care.
The new location focuses on specialty pharmacy services, particularly in managing complex conditions such as hepatitis C, aiming for disease elimination in Canada by 2030.
This expansion supports Mednow's goal of delivering high-quality, pharmacist-led patient care while driving sustainable business growth.
- Expansion into Calgary strengthens Mednow's national presence and commitment to patient care.
- Focus on specialty pharmacy allows for advanced management of complex conditions, including hepatitis C.
- Partnership with HepCURE aims to eliminate hepatitis C in Canada by 2030.
- None.
- Extends Mednow’s growing national infrastructure and presence, demonstrating Mednow’s deep commitment to meeting patients where they are to provide holistic, private, pharmacist-led patient care.
-
Initial focus on specialty pharmacy treating complex conditions with new pharmacological interventions, including screening and treatment of hepatitis C with the goal to eliminate the disease in
Canada by 2030.
The Mednow Alberta pharmacy is located at 38,
Specialty pharmacy implements new pharmacological interventions, taking an active role in helping patients manage complex conditions with the latest treatments, monitoring and advice.
With advancements in screening and new specialty pharmacy treatments available through Mednow’s partnership agreement with HepCURE, this expansion marks another milestone in the shared goal to eliminate Hepatitis C in
In
The Mednow Alberta pharmacy includes space for private pharmacist consultations, further demonstrating the company’s deep commitment to holistic, private, pharmacist-led patient care.
“We’re thrilled to deepen our presence in
About
Neither
Cautionary Note Regarding Forward-Looking Statements:
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information, including statements relating to: Mednow’s plan to expand its operations and open fulfillment centres in certain locations in 2022, Mednow’s goal of integrating the technology of its strategic business acquisitions with its core fulfillment pharmacies, the optimization of Mednow’s PillSmart TM and nutraceutical offerings, Mednow’s ability to connect with employers, specialty doctors and large pharmacies, and Mednow’s ability to acquire customers and lower costs.
Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Risk factors are set out in the Company’s final long form prospectus dated
This news release also contains future-oriented financial information and financial outlook information (collectively, “FOFI”) as defined under Canadian securities laws, prepared by Mednow’s management about Mednow’s reasonably estimated prospective results of operations, revenue, sales, and components thereof, all of which are subject to the same assumptions, risks factors, limitations and qualifications set forth in the above paragraphs. Readers are cautioned that FOFI are not guarantees of future performance, and should not be considered as such, since actual results may differ materially from those expressed in FOFI.
As a result, there can be no assurance that forward-looking information or FOFI will prove to be accurate, as actual results and future events could differ materially from those anticipated in this news release. Accordingly, readers should not place undue reliance on the forward-looking information or FOFI contained in this news release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005487/en/
Investor:
1-855-686-6300
ir@mednow.ca
Source:
FAQ
What is the significance of Mednow's new pharmacy opening in Calgary?
How does Mednow plan to address hepatitis C in Canada?
What is the stock symbol for Mednow?